No Survival Benefit from Adding Cetuximab or Panitumumab to Oxaliplatin-Based Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer in KRAS Wild Type Patients: A Meta-Analysis

✍ Scribed by Zhou, Si-wei; Huang, Yuan-yuan; Wei, Ying; Jiang, Zhi-min; Zhang, Yuan-dong; Yang, Qiong; Xie, De-rong; Goel, Ajay

• Book ID: 120188086
• Publisher: Public Library of Science
• Year: 2012
• Tongue: English
• Weight: 533 KB
• Volume: 7
• Category: Article
• ISSN: 1932-6203
• DOI: 10.1371/journal.pone.0050925